Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Oral 💊 is the game changer !!!

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Jan 25, 2021 9:09pm

85 Views

Post# 32382266

RE:RE:RE:RE:RE:Oral 💊 is the game changer !!!

Vaxil and Vaxart either way Oral would be the huge advantage to getting funding and investor attention as a oral form could be sent to Africa or South America for mass distrubution without the need of syringes or fancy -80 fridges

Jlane17 wrote: Do some research before posting check out vaxart oral pill already in clinical testing with results soon to be announced. Do some homework

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?